39 Results for "

VMAT

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "VMAT" in MCE Product Catalog:

7
7 Publications Verification
Art. -Nr.: HY-N0480
CAS. Nr.: 50-55-5
Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).
7
7 Publications Verification
Art. -Nr.: HY-N0480A
CAS. Nr.: 16994-56-2
Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).
5
5 Cited Publications
Art. -Nr.: HY-19348
CAS. Nr.: 937039-45-7
Synonyms: RGFA-8; TC-H 106; Histone Deacetylase Inhibitor VII
Forschungsgebiete:  

Neurological Disease Cancer

Pimelic Diphenylamide 106 (TC-H 106) is a slow, tight binding class I HDAC inhibitor (inhibits HDAC1, 2, and 3 with IC50 values of 150 nM, 760 nM, and 370 nM, respectively), with no activity against class II HDACs. Pimelic Diphenylamide 106 modulates dopamine concentration and protects dopamine cells by inducing VMAT2 expression. Pimelic Diphenylamide 106 can be used in the study of neuropsychiatric diseases such as attention deficit hyperactivity disorder (ADHD) .
4
4 Cited Publications
Art. -Nr.: HY-16771
CAS. Nr.: 1025504-45-3
Synonyms: NBI-98854
Target:  

Monoamine Transporter

Forschungsgebiete:  

Neurological Disease

Valbenazine (NBI-98854) is a vesicular monoamine transporter 2 (VMAT2) inhibitor with the Ki of 110-190 nM .
4
4 Cited Publications
Art. -Nr.: HY-16771A
CAS. Nr.: 1639208-54-0
Synonyms: NBI-98854 tosylate
Target:  

Monoamine Transporter

Forschungsgebiete:  

Neurological Disease

Valbenazine tosylate (NBI-98854 tosylate) is a vesicular monoamine transporter 2 (VMAT2) inhibitor with the Ki of 110-190 nM .
1
1 Cited Publications
Art. -Nr.: HY-B0590
CAS. Nr.: 58-46-8
Synonyms: Ro 1-9569
Forschungsgebiete:  

Neurological Disease

Tetrabenazine (Ro 1-9569) is a brain-penetrant and orally active VMAT2-selective ligand with human VMAT2 Ki 100 nM. Tetrabenazine binds VMAT2 to block monoamine uptake into synaptic vesicles, potentiates cytoplasmic monoamine degradation. Tetrabenazine weakly blocks dopamine D2 receptors, and increases dopamine turnover via elevated cerebrospinal fluid homovanillic acid. Tetrabenazine can be used for the research of Huntington’s disease, tardive dyskinesia, and Tourette’s syndrome .
1
1 Cited Publications
Art. -Nr.: HY-15793
CAS. Nr.: 85081-18-1
Reinheit:  98.56%
Synonyms: (+)-DTBZ; (+)-α-Dihydrotetrabenazine; (+)-α-DHTBZ
Target:  

Monoamine Transporter

Forschungsgebiete:  

Neurological Disease

NBI-98782 is a high affinity and selectivity vesicular monoamine transporter 2 (VMAT2) inhibitor with a Ki of 3 nM. NBI-98782 has antipsychotic activity .
1
1 Cited Publications
Art. -Nr.: HY-149170
CAS. Nr.: 2210244-83-8
Reinheit:  99.79%
Forschungsgebiete:  

Neurological Disease

FFN246 is a fluorescent, dual substrate of serotonin transporter (SERT) probe and vesicular monoamine transporter 2 (VMAT2) with excitation and emission spectra 392/427 nm. FFN246 can be used for labeling serotonergic neurons in mouse brain tissue through SERT-dependent accumulation .
Art. -Nr.: HY-B0590S
CAS. Nr.: 1392826-25-3
Synonyms: Ro 1-9569-d6
Tetrabenazine-d6 (Deutetrabenazine) is a deuterium-labled Tetrabenazine (HY-B0590). Tetrabenazine (Ro 1-9569) is a brain-penetrant and orally active VMAT2-selective ligand with human VMAT2 Ki 100 nM. Tetrabenazine binds VMAT2 to block monoamine uptake into synaptic vesicles, potentiates cytoplasmic monoamine degradation. Tetrabenazine weakly blocks dopamine D2 receptors, and increases dopamine turnover via elevated cerebrospinal fluid homovanillic acid. Tetrabenazine can be used for the research of Huntington’s disease, tardive dyskinesia, and Tourette’s syndrome .
Art. -Nr.: HY-B0590A
CAS. Nr.: 718635-93-9
Synonyms: Ro 1-9569 Racemate
Forschungsgebiete:  

Neurological Disease

Tetrabenazine (Ro 1-9569) Racemate is a brain-penetrant and orally active VMAT2-selective ligand with human VMAT2 Ki 100 nM. Tetrabenazine Racemate binds VMAT2 to block monoamine uptake into synaptic vesicles, potentiates cytoplasmic monoamine degradation. Tetrabenazine Racemate weakly blocks dopamine D2 receptors, and increases dopamine turnover via elevated cerebrospinal fluid homovanillic acid. Tetrabenazine Racemate can be used for the research of Huntington’s disease, tardive dyskinesia, and Tourette’s syndrome .
Art. -Nr.: HY-W677684
CAS. Nr.: 742058-34-0
Forschungsgebiete:  

Others

Nurr1 agonist 2 (Compound 7) is a Nurr1 agonist (EC50: 0.07 μM). Nurr1 agonist 2 binds to the recombinant Nurr1 ligand binding domain (LBD) with a Kd value of 0.14 μM. Nurr1 agonist 2 increases the Nurr1-regulated genes tyrosine hydroxylase (TH) and vesicular amino acid transporter 2 (VMAT2) mRNA expression .
Art. -Nr.: HY-110334
CAS. Nr.: 1883548-88-6
Target:  

Fluorescent Dye

Forschungsgebiete:  

Others

FFN 206 dihydrochloride, a fluorescent probe, is used as an excellent Vesicular Monoamine Transporter 2 (VMAT2) substrate with an apparent Km of 1.16 μM. FFN 206 dihydrochloride is capable of detecting VMAT2 activity in intact cells using fluorescence microscopy, with subcellular localization to VMAT2-expressing acidic compartments without apparent labeling of other organelles .
Art. -Nr.: HY-N0480S
CAS. Nr.: 84759-11-5
Reserpine-d9 is the deuterium labeled Reserpine. Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).
Art. -Nr.: HY-N0480R
CAS. Nr.: 50-55-5
Reserpine (Standard) is the analytical standard of Reserpine. This product is intended for research and analytical applications. Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).
Art. -Nr.: HY-131006
CAS. Nr.: 2080306-27-8
Reinheit:  ≥99.0%
Target:  

Monoamine Transporter

Forschungsgebiete:  

Neurological Disease

FFN200 dihydrochloride, a fluorescent substrate of VMAT2, selectively trace monoamine exocytosis in both neuronal cell culture and brain tissue. The fluorescence excitation and emission maxima of FFN200 are determined to be 352 and 451 nm, respectively .
Art. -Nr.: HY-B0590B
CAS. Nr.: 1026016-83-0
Synonyms: (+)-TBZ; (3R,11bR)-TBZ; (3R,11bR)-Tetrabenazine
Target:  

Monoamine Transporter

Forschungsgebiete:  

Cancer

(+)-Tetrabenazine ((+)-TBZ) is the enantiomer of Tetrabenazine (HY-B0590) and is also a Vesicular Monoamine Transporter 2 (VMAT2) inhibitor with a rat Ki of 4.61 nM. (+)-Tetrabenazine inhibits monoamine uptake into granular vesicles of presynaptic neurons. (+)-Tetrabenazine is 3 times more active than (-)-Tetrabenazine. (+)-Tetrabenazine can be used for the research of Huntington's disease and hyperkinetic movement disorders (including chorea) .
Art. -Nr.: HY-G0025
CAS. Nr.: 924854-60-4
Synonyms: (-)-β-Dihydrotetrabenazine; (-)-β-HTBZ
Forschungsgebiete:  

Neurological Disease

Tetrabenazine Metabolite is an active metabolite of Tetrabenazine. Tetrabenazine Metabolite is a vesicular monoamine transporter 2 (VMAT2) inhibitor with a high affinity (Ki=13.4 nM) . Tetrabenazine Metabolite is be developed for the treatment of chorea associated with Huntington’s disease and other hyperkinetic disorders .
Art. -Nr.: HY-B0590D
CAS. Nr.: 1026016-84-1
Synonyms: (-)-TBZ; (3S,11bS)-TBZ; (3S,11bS)-Tetrabenazine
Target:  

Monoamine Transporter

Forschungsgebiete:  

Neurological Disease

(-)-Tetrabenazine ((-)-TBZ; compound 13) is an enantiomer of Tetrabenazine (HY-B0590). (+)-Tetrabenazine proves 3-fold more active than (-)-Tetrabenazine in inhibiting vesicular monoamine transporter 2 (VMAT2) .
Art. -Nr.: HY-W681822
CAS. Nr.: 924854-62-6
Synonyms: R,S,S-DHTBZ
Forschungsgebiete:  

Neurological Disease

(R,S,S)-Dihydrotetrabenazine (R,S,S-DHTBZ) is a kind of discrete isomeric secondary alcohol metabolites of Tetrabenazine (TBZ, HY-B0590), is a poor VMAT2 inhibitor (Ki = 690 nM) .
Art. -Nr.: HY-141554
CAS. Nr.: 3466-75-9
Reinheit:  99.23%
Synonyms: DHTBZ
Target:  

Monoamine Transporter

Forschungsgebiete:  

Neurological Disease

Dihydrotetrabenazine (DHTBZ) is the active metabolite of Tetrabenazine (HY-B0590). Dihydrotetrabenazine is the inhibitor for human vesicular monoamine transporter 2 (VMAT2), that reduces monoamine content in presynaptic neurons, and can be used in movement disorder research .